Search
for
Sort by
Research 781–810 of 1000+
- Solanum nigrum L. in COVID-19 and post-COVID complications: a propitious candidate
- A case of extensive alopecia areata following Pfizer‐BioNTech BNT162b2 mRNA COVID‐19 vaccine with favorable outcome
- Roles of steroid receptors in the lung and COVID-19
- The brief overview, antivirus and anti-SARS-CoV-2 activity, quantitative methods, and pharmacokinetics of cepharanthine: a potential small-molecule drug against COVID-19
- Risk factors associated with development and persistence of long COVID
- The impact of certain genetic variants (single nucleotide polymorphisms) on incidence and severity of COVID‐19
- Shedding light on therapeutics in alopecia and their relevance to COVID-19
- Drug interactions between common dermatological medications and the oral anti-COVID-19 agents nirmatrelvir-ritonavir and molnupiravir
- Efficacy of QR678 Neo<sup>®</sup> hair growth factor formulation for the treatment of hair loss in Covid‐19‐induced persistent Telogen Effluvium—A prospective, clinical, single‐blind study
- Proxalutamide (GT0918) Reduces the Rate of Hospitalization in mild-to-moderate COVID-19 Female Patients: A Randomized Double-Blinded Placebo-Controlled Two-Arm Parallel Trial
- 5-Alpha-Reductase Inhibitors Reduce Remission Time of COVID-19: Results From a Randomized Double Blind Placebo Controlled Interventional Trial in 130 SARS-CoV-2 Positive Men
- Can hydroxychloroquine be useful in the prevention of COVID-19? An Italian survey in dermatologic and rheumatologic patients already under treatment
- Impact and prevalence of comorbidities and complications on the severity of COVID-19 in association with age, gender, obesity, and pre-existing smoking: A meta-analysis
- Online search interest in long-term symptoms of coronavirus disease 2019 during the COVID-19 pandemic in Japan: Infodemiology study using the most visited search engine in Japan
- Application of Kampo Medicines for Treatment of General Fatigue Due to Long COVID
- Protective trend of anti-androgen therapy during the COVID-19 pandemic: A meta-analysis
- Meta-analysis of post-traumatic stress disorder and COVID-19 in patients discharged
- Genetic correlation analysis does not associate male pattern baldness with COVID-19
- Fármacos de uso frecuente en dermatología como terapia para COVID-19
- Safety and efficacy of oral administrated cepharanthine in non-hospitalized, asymptomatic or mild COVID-19 patients: a Double-blind, randomized, placebo-controlled trial
- Androgens’ Role in Severity and Mortality Rates of COVID-19
- Social isolation: main dermatosis and the impact of stress during the COVID-19 pandemic
- Extraordinary claims without extraordinary evidence: controversy on anti‐androgen therapy for COVID‐19
- Manifestaciones clínicas y complicaciones de la enfermedad por coronavirus 2019 (COVID-19): revisión de la literatura
- Skin cancer prevention in the Polish population during the COVID-19 pandemic
- Platelet‐rich plasma in the treatment of alopecia areata after COVID‐19 vaccination
- The Impact of Immune-Modifying Treatments for Skin Diseases on the Immune Response to COVID-19 Vaccines: a Narrative Review
- Manifestaciones dermatológicas asociadas a la gravedad de la infección por COVID-19. Estudio observacional transversal retrospectivo de 144 pacientes
- Association of androgenetic alopecia with a more severe form of COVID-19 infection
- Anxiety and depression disorders on health workers in COVID and non-COVID wards of Sanglah Hospital